QuidelOrtho (QDEL) Net Equity Issued and Repurchased (2021 - 2026)
QuidelOrtho (QDEL) reported Net Equity Issued and Repurchased of $1.8 million for Q1 2026, down 40.0% on a YoY basis from $3.0 million in Q1 2025, and up 1700.0% sequentially from $100000.0 in Q4 2025.
QuidelOrtho (QDEL) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends
QuidelOrtho (QDEL) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $1.8 million in Q1 2026.
- For the quarter ending Q1 2026, Net Equity Issued and Repurchased fell 40.0% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (down 34.67% YoY), and the FY2025 full-year result was $6.1 million, up 22.0% from the prior year.
- Net Equity Issued and Repurchased climbed to $1.8 million in Q1 2026, from $100000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $19.1 million in Q1 2023 to a low of $100000.0 in Q2 2025.
- A 5-year average of $3.4 million and a median of $2.4 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
- Peak annual rise in Net Equity Issued and Repurchased reached 625.0% in 2025, while the deepest fall reached 97.56% in 2025.
- Tracing QDEL's Net Equity Issued and Repurchased over 5 years: stood at $3.5 million in 2022, then changed by 0.0% to $3.5 million in 2023, then sank by 88.57% to $400000.0 in 2024, then tumbled by 75.0% to $100000.0 in 2025, then soared by 1700.0% to $1.8 million in 2026.
- Business Quant data shows QDEL's Net Equity Issued and Repurchased at $1.8 million in Q1 2026, $100000.0 in Q4 2025, and $2.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | QuidelOrtho | 1.13 Bn | 990.36 Mn | - | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 1.80 Mn |
| Mar 29, 2026 | 1.80 Mn |
| Dec 28, 2025 | 100,000.00 |
| Dec 28, 2025 | 100,000.00 |
| Sep 28, 2025 | 2.90 Mn |
| Sep 28, 2025 | 2.90 Mn |
| Jun 29, 2025 | 100,000.00 |
| Jun 29, 2025 | 100,000.00 |
| Mar 30, 2025 | 3.00 Mn |
| Mar 30, 2025 | 3.00 Mn |
| Sep 29, 2024 | 400,000.00 |
| Sep 29, 2024 | 400,000.00 |
| Jun 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | 4.10 Mn |
| Mar 31, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 3.50 Mn |
| Dec 31, 2023 | 3.50 Mn |
| Oct 1, 2023 | 800,000.00 |
| Oct 1, 2023 | 800,000.00 |